Illumina (ILMN) announced the appointment of Eric D. Green, M.D., Ph.D., as Chief Medical Officer, effective February 2. In this role reporting to the CEO, Dr. Green will accelerate the company’s mission to drive a revolution in medicine by unlocking the power of the genome. Dr. Green is widely regarded as one of the most influential leaders in genomics since the field’s inception. He joins Illumina after more than three decades at the National Human Genome Research Institute at the U.S. National Institutes of Health. As the NHGRI Director from 2009 to 2025, he helped guide the transformation of genomics from a primarily research-driven field into a foundational element of modern medicine and public health.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ILMN:
- Illumina to name Eric Green chief medical officer, Endpoints News reports
- Illumina price target raised to $140 from $115 at TD Cowen
- Illumina price target raised to $155 from $142 at Evercore ISI
- Illumina price target raised to $144 from $114 at Guggenheim
- Illumina price target raised to $130 from $112 at Canaccord